Gynecologic Oncology

Gynecol Oncol · ISSN (print) 0090-8258 · ISSN (e) 1095-6859 · 339 papers in corpus
observational 2010
doi:10.1016/j.ygyno.2009.10.069 ·PMID:19922988

OBJECTIVE: To determine the incidence of clinically significant venous thromboembolism (VTE) in women diagnosed with clear cell carcinoma of the ovary (CCC-O) interpreted in the context of Centers for Medicare and Medicaid Services (CMS) 'n…

rct 2009
doi:10.1016/j.ygyno.2009.06.021 ·PMID:19596139

OBJECTIVE: Serum CA-125 values have been advocated in the monitoring of ovarian cancer patients receiving intravenous (IV) chemotherapy. This evaluation sought to determine if the CA-125 test can be used to monitor treatment effect among pa…

nonrandomized-trial 2009
doi:10.1016/j.ygyno.2008.08.031 ·PMID:18851871

INTRODUCTION: Patients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk f…

other 2009
doi:10.1016/j.ygyno.2008.09.043 ·PMID:19007974

OBJECTIVES: Ovarian epithelial carcinoma can be subdivided into separate histological subtypes including clear cell, endometrioid, mucinous, and serous. These carcinoma subtypes may represent distinctive pathways of tumorigenesis and diseas…

observational 2009
doi:10.1016/j.ygyno.2009.06.032 ·PMID:19615727

OBJECTIVE: Many ovarian carcinomas are presumed to arise within ovarian cortical inclusion cysts (CICs). This study examined the frequency of ovarian CICs in relation to epidemiologic risk factors in women with BRCA1 and BRCA2 (BRCA+) mutat…

case-report 2009
doi:10.1016/j.ygyno.2009.07.033 ·PMID:19712965

BACKGROUND: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. CASE: We present a rare case of extragenital adeno…

other 2009
doi:10.1016/j.ygyno.2009.05.014 ·PMID:19481241

OBJECTIVES: Ovarian cancer is the fourth leading cause of cancer-related death among women in the US largely due to late detection secondary to unreliable symptomology and screening tools without adequate resolution. Optical coherence tomog…

observational 2009
doi:10.1016/j.ygyno.2009.05.001 ·PMID:19464044

OBJECTIVE: Women with ovarian carcinoma experience poor survival because symptoms are vague and diagnosis is unlikely at an early stage. The objective of this study was to identify a set of symptoms that might assist gynecologists and other…

other 2009
doi:10.1016/j.ygyno.2008.09.037 ·PMID:19007973

OBJECTIVE(S): The poor prognosis associated with ovarian cancer is due to the lack of overt early symptoms and the absence of reliable diagnostic screening methods. Since many tumors overexpress anti-apoptotic proteins, the purpose of this …

observational 2008
doi:10.1016/j.ygyno.2008.01.012 ·PMID:18342932

BACKGROUND: Early serous carcinomas predominate in the fimbria of women with BRCA mutations (BRCA+). An entity in non-neoplastic mucosa sharing several properties of early serous carcinomas--the "p53 signature"--has been described in the di…

observational 2008
doi:10.1016/j.ygyno.2008.07.036 ·PMID:18757082

OBJECTIVES: To define patterns of aberrant DNA methylation, p53 mutation and Her-2/neu overexpression in tissues from benign (n=29), malignant (n=100), and border line malignant ovaries (n=10), as compared to normal (n=68) ovarian tissues. …

other 2008
doi:10.1016/j.ygyno.2008.05.029 ·PMID:18635252

OBJECTIVE: To analyze the incidence of diagnostic discrepancy between frozen-section and final diagnosis of the endocervical margin at time of radical trachelectomy and to apply an objective scoring system to non-invasive endocervical gland…

case-report 2008
doi:10.1016/j.ygyno.2007.08.079 ·PMID:18028990

INTRODUCTION: Focused ultrasound under real-time MR guidance and control (MRgFUS) can be used for the thermal ablation of tissue. Currently this technique is used clinically for the noninvasive treatment of uterine leiomyomas and is in clin…

observational 2008
doi:10.1016/j.ygyno.2008.05.025 ·PMID:18639330

OBJECTIVE: The aim of this study is to investigate whether the presence of endometriosis is a prognostic factor in patients diagnosed with clear cell carcinoma (CCC) of the ovary. METHODS: Retrospective chart review was performed to all pa…

rct 2008
doi:10.1016/j.ygyno.2008.05.006 ·PMID:18586313

OBJECTIVE: To determine the epidemiology of CA-125 in women without ovarian cancer. METHODS: We analyzed demographic, medical and lifestyle characteristics related to CA-125, measured using the Centocor CA-125II RIA assay, among 25,608 mul…

review 2007
doi:10.1016/j.ygyno.2007.06.008 ·PMID:17631951

OBJECTIVE: To assess the sensitivity and positive predictive value (PPV) of intraoperative frozen section diagnosis of borderline tumors of the ovary (BTO). METHODS: Retrospective analysis at the Department of Obstetrics and Gynecology, Un…

diagnostic-accuracy 2007
doi:10.1016/j.ygyno.2007.08.009 ·PMID:17920110

OBJECTIVE: Currently available tumor markers for ovarian cancer are still inadequate in both sensitivity and specificity to be used for population-based screening. Artificial neural network (ANN) as a modeling tool has demonstrated its abil…

other 2007
doi:10.1016/j.ygyno.2007.08.085 ·PMID:17949797

OBJECTIVE: To assess the feasibility and surgical outcome of laparoscopic surgery among women with large benign ovarian cysts. METHODS: We conducted a prospective study applying laparoscopic surgery among women with ovarian cysts whose max…

observational 2007
doi:10.1016/j.ygyno.2007.08.002 ·PMID:17825884

OBJECTIVE: Several chronic diseases have been hypothesized to affect the risk of subsequent gynecologic malignancies, possibly through shared hormonal mechanisms. METHODS: Using record linkage techniques, we assessed the relationships betw…

other 2007
doi:10.1016/j.ygyno.2007.04.022 ·PMID:17532030

OBJECTIVES: Early detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect early stage disease, but few urine markers have been studied. Mesothelin has been detected…

review 2006
doi:10.1016/j.ygyno.2005.11.033 ·PMID:16473398

OBJECTIVE: This review was aimed to critically evaluate observational, cohort, and case-control studies performed so far in order to assess the association between endometriosis and malignant diseases. Based on the observations herein prese…

other 2006
doi:10.1016/j.ygyno.2005.08.060 ·PMID:16256178

OBJECTIVES: Despite great advances in therapeutic management, the mortality rate for ovarian cancer has remained relatively stable over the past 50 years. This study was designed to evaluate the expression of B7-H4 protein, recently identif…

case-report 2006
doi:10.1016/j.ygyno.2006.06.044 ·PMID:16996119

BACKGROUND: Malignant transformation of endometriosis is an infrequent complication of endometriosis. Extragonadal disease is uncommon. CASE: 55-year-old female presented with postmenopausal bleeding. Physical examination revealed a 2-cm p…

case-report 2006
doi:10.1016/j.ygyno.2006.01.001 ·PMID:16527336

BACKGROUND: Ovarian choriocarcinoma (CC) is rarely encountered as compared to uterine CC. Furthermore, ovarian CC coexisting with surface epithelial tumor is very rare. CASE: A 50-year-old postmenopausal woman, gravida 0, was admitted to o…

case-report 2006
doi:10.1016/j.ygyno.2005.12.022 ·PMID:16439005

BACKGROUND: Extragastrointestinal stromal tumors (eGISTs) are rare mesenchymal-derived tumors arising outside of the GI tract. eGISTs are often histologically confused with leiomyosarcoma. Distinction between eGIST and leiomyosarcoma is cri…